FDA Adverse Event Injury Summary report: N

PROLIFT PELVIC FLOOR REPAIR

MDR report key: 2931246 · Received January 28, 2013

Report

Report Number
2210968-2013-00568
Event Type
Injury
Date Received
January 28, 2013
Report Date
January 9, 2013
Manufacturer
ETHICON, INC.
Product Code
OTP
PMA / PMN Number
K071512
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

IT WAS REPORTED BY AN ATTORNEY THAT THE PATIENT UNDERWENT PARTIAL EXCISION OF MESH ON (B)(6) 2014. (B)(4).

Additional Manufacturer Narrative · 1

THE PATIENT UNDERWENT MESH IMPLANTATION ON (B)(6) 2006 DUE TO PROLAPSE. FOLLOWING INSERTION, THE PATIENT EXPERIENCED PAIN, EROSION, BLEEDING, INFECTION, URINARY/BOWEL PROBLEMS AND DYSPAREUNIA. IT WAS REPORTED THAT IN FALL 2006 THE PATIENT UNDERWENT INJECTION IN URETHRA DUE TO CONTINUED INCONTINENCE AND MESH NOT WORKING. (B)(4).

Additional Manufacturer Narrative · 1

(B)(4). CONCLUSION: NO CONCLUSION CAN BE DRAWN AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE OBTAINED, A SUPPLEMENTAL 3500A FORM WILL BE SUBMITTED ACCORDINGLY. THIS IS ONE OF TWO MEDWATCHES BEING SUBMITTED. SEE ALSO MEDWATCH 2210968-2013-00567. THE SAME PATIENT IS REPRESENTED IN EACH MEDWATCH. IN ADDITION, A REVIEW OF THE BATCH MANUFACTURING RECORDS WAS CONDUCTED AND THE BATCH MET ALL FINISHED GOODS RELEASE CRITERIA. (B)(6).

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT UNDERWENT A GYNECOLOGICAL PROCEDURE ON (B)(6) 2006 AND MESH WAS USED. THE PATIENT EXPERIENCED PAIN, EROSION OF HER INTERNAL BODILY TISSUE AND OTHER INJURIES FOLLOWING THE PROCEDURE. IT WAS REPORTED THAT THE PATIENT HAS UNDERGONE ADDITIONAL SURGERIES AND REVISIONARY PROCEDURES. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
36417 PROLIFT PELVIC FLOOR REPAIR MESH, SURGICAL, POLYMERIC OTP ETHICON, INC. NA 1377567

Patients

Seq Age Sex Outcome Treatment
1 50 YR Required Intervention